These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 17532857

  • 21. Assessing the attitudes to prostate cancer treatment among European male patients.
    Schulman C.
    BJU Int; 2007 Jul; 100 Suppl 1():6-11. PubMed ID: 17593202
    [Abstract] [Full Text] [Related]

  • 22. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
    Davison BJ, Goldenberg SL.
    BJU Int; 2011 Dec; 108(11):1787-93. PubMed ID: 21507187
    [Abstract] [Full Text] [Related]

  • 23. Decision analyses in consideration of treatment strategies for patients with biochemical failure after curative therapy on clinically localized prostate cancer in the prostate-specific antigen era.
    Shimizu F, Igarashi A, Fukuda T, Kawachi Y, Minowada S, Ohashi Y, Fujime M.
    Jpn J Clin Oncol; 2007 Oct; 37(10):763-74. PubMed ID: 17956899
    [Abstract] [Full Text] [Related]

  • 24. Men's perspectives on the impact of prostate cancer: implications for oncology nurses.
    Fitch MI, Gray R, Franssen E, Johnson B.
    Oncol Nurs Forum; 2000 Sep; 27(8):1255-63. PubMed ID: 11013906
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Clinical events in prostate cancer lifestyle trial: results from two years of follow-up.
    Frattaroli J, Weidner G, Dnistrian AM, Kemp C, Daubenmier JJ, Marlin RO, Crutchfield L, Yglecias L, Carroll PR, Ornish D.
    Urology; 2008 Dec; 72(6):1319-23. PubMed ID: 18602144
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Active surveillance for the management of prostate cancer in a contemporary cohort.
    Dall'Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll PR.
    Cancer; 2008 Jun 15; 112(12):2664-70. PubMed ID: 18433013
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Understanding the concept of uncertainty in patients with indolent lymphoma.
    Elphee EE.
    Oncol Nurs Forum; 2008 May 15; 35(3):449-54. PubMed ID: 18467294
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Communicating effectively with the patient and family about treatment options for prostate cancer.
    Kunkel EJ, Myers RE, Lartey PL, Oyesanmi O.
    Semin Urol Oncol; 2000 Aug 15; 18(3):233-40. PubMed ID: 10975496
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ, Brawer MK, Barry MJ, Jones KM, Kwon Y, Gingrich JR, Aronson WJ, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Fox S.
    Contemp Clin Trials; 2009 Jan 15; 30(1):81-7. PubMed ID: 18783735
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.